Company Filing History:
Years Active: 2024
Title: Harbani Kaur Malik Chaudhry: A Pioneer in Immunology Innovation
Introduction
Harbani Kaur Malik Chaudhry, an esteemed inventor based in Oakland, CA, has made significant contributions to the field of immunology through her innovative research. With a portfolio of two patents, her work has focused on developing cutting-edge immunotherapies that harness the power of the immune system to combat various diseases.
Latest Patents
Chaudhry's latest patents include groundbreaking advancements in the field of immune cell engineering. The first patent, titled "Immune cells having co-expressed shRNAS and logic gate systems," introduces recombinant nucleic acids that code for chimeric priming receptors binding to ALPG/P, as well as chimeric antigen receptors targeting MSLN. Additionally, this patent details shRNA targeting FAS, PTPN2, and/or TOX, along with systems to express these proteins and shRNA within the cells.
The second patent, "Agonistic anti-IL-2R antibodies and methods of use," outlines various types of anti-IL2R antibodies and their applications. This patent elucidates methods for producing such antibodies, as well as pharmaceutical compositions that incorporate them. These antibodies are integral in treating diseases linked to the IL2/IL2R signaling pathway, showcasing Chaudhry's commitment to advancing therapeutic options.
Career Highlights
Throughout her career, Harbani Kaur Malik Chaudhry has held influential positions at prestigious firms such as Teneobio, Inc. and Arsenal Biosciences, Inc. Her work in these companies has been pivotal in driving forward innovations in antibody therapy and gene editing technologies.
Collaborations
Chaudhry has collaborated with esteemed colleagues, including Katherine Harris and Nathan D. Trinklein. These partnerships have permitted knowledge exchange and fostered an environment where innovative ideas can be transformed into practical applications within the biotechnology sector.
Conclusion
Harbani Kaur Malik Chaudhry stands as a testament to the power of innovation in the field of immunology. Her patents reflect her dedication to improving therapeutic strategies for diseases affected by immune system pathways. As her career progresses, Chaudhry is poised to continue influencing the trajectory of scientific discovery and application in immunotherapeutics.